Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taebo Sim

Showing results (21-30 of 121) with videos related to

Pageof 13
Sort By:
European Journal of Medicinal Chemistry|November 5, 2016
Identification of a novel 5-amino-3-(5-cyclopropylisoxazol-3-yl)-1-isopropyl-1H-pyrazole-4-carboxamide as a specific RET kinase inhibitorHojong Yoon, Injae Shin, Yunju Nam, et al.
Bioorganic & Medicinal Chemistry Letters|July 24, 2012
Development of 'DFG-out' inhibitors of gatekeeper mutant kinasesHwan Geun Choi, Jianming Zhang, Ellen Weisberg, et al.
International Journal of Nanomedicine|August 11, 2017
In situ imaging of quantum dot-AZD4547 conjugates for tracking the dynamic behavior of fibroblast growth factor receptor 3Gyoyeon Hwang, Hyeonhye Kim, Hojong Yoon, et al.
ACS Medicinal Chemistry Letters|June 26, 2018
Development of Highly Potent and Selective Steroidal Inhibitors and Degraders of CDK8John M Hatcher, Eric S Wang, Liv Johannessen, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 26, 2015
Discovery of a broad spectrum antiproliferative agent with selectivity for DDR1 kinase: cell line-based assay, kinase panel, molecular docking, and toxicity studiesAhmed Elkamhawy, Jung-Eun Park, Nam-Chul Cho, et al.
ACS Omega|August 29, 2019
Raman-Based in Situ Monitoring of Changes in Molecular Signatures during Mitochondrially Mediated ApoptosisHyeon Jeong Shin, Ji Hye Lee, Yong Duk Kim, et al.
European Journal of Medicinal Chemistry|May 20, 2026
Identification of RET PROTAC with excellent degradation efficiency against medullary thyroid carcinomaJaewon Song, Sugene Lim, Eunhye Jeon, et al.
European Journal of Medicinal Chemistry|September 17, 2024
Targeted degradation of METTL3 against acute myeloid leukemia and gastric cancerKyubin Hwang, Juhyeon Bae, Yoo-Lim Jhe, et al.
Journal of Medicinal Chemistry|April 18, 2022
Identification of Pyridinyltriazine Derivatives as Potent panFGFR Inhibitors against Gatekeeper Mutants for Overcoming Drug ResistanceSeongShick Ryu, Yunju Nam, Namkyoung Kim, et al.
European Journal of Medicinal Chemistry|July 21, 2023
Synthesis and antibacterial activities of baulamycin A inspired derivativesNamkyoung Kim, Sandip Sengupta, Jiwon Lee, et al.
Pageof 13

Showing results (21-30 of 121) with videos related to

Sort By:
Pageof 13
European Journal of Medicinal Chemistry|November 5, 2016
Identification of a novel 5-amino-3-(5-cyclopropylisoxazol-3-yl)-1-isopropyl-1H-pyrazole-4-carboxamide as a specific RET kinase inhibitorHojong Yoon, Injae Shin, Yunju Nam, et al.
Bioorganic & Medicinal Chemistry Letters|July 24, 2012
Development of 'DFG-out' inhibitors of gatekeeper mutant kinasesHwan Geun Choi, Jianming Zhang, Ellen Weisberg, et al.
International Journal of Nanomedicine|August 11, 2017
In situ imaging of quantum dot-AZD4547 conjugates for tracking the dynamic behavior of fibroblast growth factor receptor 3Gyoyeon Hwang, Hyeonhye Kim, Hojong Yoon, et al.
ACS Medicinal Chemistry Letters|June 26, 2018
Development of Highly Potent and Selective Steroidal Inhibitors and Degraders of CDK8John M Hatcher, Eric S Wang, Liv Johannessen, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 26, 2015
Discovery of a broad spectrum antiproliferative agent with selectivity for DDR1 kinase: cell line-based assay, kinase panel, molecular docking, and toxicity studiesAhmed Elkamhawy, Jung-Eun Park, Nam-Chul Cho, et al.
ACS Omega|August 29, 2019
Raman-Based in Situ Monitoring of Changes in Molecular Signatures during Mitochondrially Mediated ApoptosisHyeon Jeong Shin, Ji Hye Lee, Yong Duk Kim, et al.
European Journal of Medicinal Chemistry|May 20, 2026
Identification of RET PROTAC with excellent degradation efficiency against medullary thyroid carcinomaJaewon Song, Sugene Lim, Eunhye Jeon, et al.
European Journal of Medicinal Chemistry|September 17, 2024
Targeted degradation of METTL3 against acute myeloid leukemia and gastric cancerKyubin Hwang, Juhyeon Bae, Yoo-Lim Jhe, et al.
Journal of Medicinal Chemistry|April 18, 2022
Identification of Pyridinyltriazine Derivatives as Potent panFGFR Inhibitors against Gatekeeper Mutants for Overcoming Drug ResistanceSeongShick Ryu, Yunju Nam, Namkyoung Kim, et al.
European Journal of Medicinal Chemistry|July 21, 2023
Synthesis and antibacterial activities of baulamycin A inspired derivativesNamkyoung Kim, Sandip Sengupta, Jiwon Lee, et al.
Pageof 13